Overview

Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts

Status:
Completed

Trial end date:
2020-11-15

Target enrollment:

Participant gender:

Summary

- organizing an entirely no in-person contact clinical trial is feasible during a 22 COVID-19 pandemic 23 - Remote smartphone 6-lead ECG monitoring is possible even in a group unfamiliar 24 with the technology 25 - Hydroxychloroquine used prophylactically at 200 mg BID had no observable 26 cardiotoxicity 27 - Additional study using this technique is warranted to look at reliability and cost-28 effectiveness

Phase:

Phase 4

Details

Lead Sponsor:

Bryn Mawr Hospital

Collaborators:

Bryn Mawr Hospital Foundation
Cotswold Foundation
Sharpe-Strumia Research Foundation

Treatments:

Hydroxychloroquine